Skip to main content
Top
Published in: The European Journal of Health Economics 7/2016

Open Access 01-09-2016 | Original Paper

Overpaying morbidity adjusters in risk equalization models

Authors: R. C. van Kleef, R. C. J. A. van Vliet, W. P. M. M. van de Ven

Published in: The European Journal of Health Economics | Issue 7/2016

Login to get access

Abstract

Most competitive social health insurance markets include risk equalization to compensate insurers for predictable variation in healthcare expenses. Empirical literature shows that even the most sophisticated risk equalization models—with advanced morbidity adjusters—substantially undercompensate insurers for selected groups of high-risk individuals. In the presence of premium regulation, these undercompensations confront consumers and insurers with incentives for risk selection. An important reason for the undercompensations is that not all information with predictive value regarding healthcare expenses is appropriate for use as a morbidity adjuster. To reduce incentives for selection regarding specific groups we propose overpaying morbidity adjusters that are already included in the risk equalization model. This paper illustrates the idea of overpaying by merging data on morbidity adjusters and healthcare expenses with health survey information, and derives three preconditions for meaningful application. Given these preconditions, we think overpaying may be particularly useful for pharmacy-based cost groups.
Literature
1.
go back to reference Federal register: Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2014. Federal Register vol. 77, No. 236, December 7 (2012) Federal register: Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2014. Federal Register vol. 77, No. 236, December 7 (2012)
2.
go back to reference Buchner, F., Goepffarth, D., Wasem, J.: The new risk adjustment formula in Germany: implementation and first experiences. Health Policy 109, 253–262 (2013)CrossRefPubMed Buchner, F., Goepffarth, D., Wasem, J.: The new risk adjustment formula in Germany: implementation and first experiences. Health Policy 109, 253–262 (2013)CrossRefPubMed
3.
go back to reference Van Kleef, R.C., Van Vliet, R.C.J.A., Van de Ven, W.P.M.M.: Risk equalization in the Netherlands: an empirical evaluation. Expert Rev. Pharmacoecon. Outcome Res. 13, 829–839 (2013)CrossRef Van Kleef, R.C., Van Vliet, R.C.J.A., Van de Ven, W.P.M.M.: Risk equalization in the Netherlands: an empirical evaluation. Expert Rev. Pharmacoecon. Outcome Res. 13, 829–839 (2013)CrossRef
4.
go back to reference Ellis, R.P., McGuire, T.G.: Predictability and predictiveness in health care spending. J. Health Econ. 26, 25–48 (2007)CrossRefPubMed Ellis, R.P., McGuire, T.G.: Predictability and predictiveness in health care spending. J. Health Econ. 26, 25–48 (2007)CrossRefPubMed
5.
go back to reference Newhouse, J.P.: Reimbursing health plans and health providers: efficiency in production versus selection. J. Econ. Lit. 34, 1236–1263 (1996) Newhouse, J.P.: Reimbursing health plans and health providers: efficiency in production versus selection. J. Econ. Lit. 34, 1236–1263 (1996)
6.
go back to reference Glazer, J., McGuire, T.G.: Optimal risk adjustment in markets with adverse selection: an application to managed care. Am. Econ. Rev. 90, 1055–1071 (2000)CrossRef Glazer, J., McGuire, T.G.: Optimal risk adjustment in markets with adverse selection: an application to managed care. Am. Econ. Rev. 90, 1055–1071 (2000)CrossRef
7.
go back to reference Glazer, J., McGuire, T.G.: Setting health plan premiums to ensure efficient quality in health care: minimum variance optimal risk adjustment. J. Public Econ. 84, 153–173 (2002)CrossRef Glazer, J., McGuire, T.G.: Setting health plan premiums to ensure efficient quality in health care: minimum variance optimal risk adjustment. J. Public Econ. 84, 153–173 (2002)CrossRef
8.
go back to reference Van de Ven, W.P.M.M., Ellis, R.P.: Risk adjustment in competitive health insurance markets. In: Culyer, A.J., Newhouse, J.P. (eds.) Handbook of health economics, pp. 755–845. North-Holland, Amsterdam (2000) Van de Ven, W.P.M.M., Ellis, R.P.: Risk adjustment in competitive health insurance markets. In: Culyer, A.J., Newhouse, J.P. (eds.) Handbook of health economics, pp. 755–845. North-Holland, Amsterdam (2000)
9.
go back to reference McGuire, T.G., Glazer, J., Newhouse, J.P., Normand, S.L., Shi, J., Sinaiko, A.D., Zuvekas, S.: Integrating risk adjustment and enrollee premiums in health plan payment. J. Health Econ. 32, 1263–1277 (2013)CrossRefPubMed McGuire, T.G., Glazer, J., Newhouse, J.P., Normand, S.L., Shi, J., Sinaiko, A.D., Zuvekas, S.: Integrating risk adjustment and enrollee premiums in health plan payment. J. Health Econ. 32, 1263–1277 (2013)CrossRefPubMed
10.
go back to reference Jack, W.: Optimal risk adjustment with adverse selection and spatial competition. J. Health Econ. 25, 908–926 (2006)CrossRefPubMed Jack, W.: Optimal risk adjustment with adverse selection and spatial competition. J. Health Econ. 25, 908–926 (2006)CrossRefPubMed
11.
go back to reference Bijlsma, M., Boone, J., Zwart, G.: Competition leverage: how the demand side affects optimal risk adjustment. RAND J. Econ. 45, 792–815 (2014)CrossRef Bijlsma, M., Boone, J., Zwart, G.: Competition leverage: how the demand side affects optimal risk adjustment. RAND J. Econ. 45, 792–815 (2014)CrossRef
12.
go back to reference Pope, G.C., Ellis, R.P., Ash, A.S., Liu, C.F., Ayanian, J.Z., Bates, D.W., Burstin, H., Iezzoni, L.I., Ingber, M.J.: Principal inpatient diagnostic cost group model for medicare risk adjustment. Health Care Financ. Rev. 21, 93–118 (2000)PubMedPubMedCentral Pope, G.C., Ellis, R.P., Ash, A.S., Liu, C.F., Ayanian, J.Z., Bates, D.W., Burstin, H., Iezzoni, L.I., Ingber, M.J.: Principal inpatient diagnostic cost group model for medicare risk adjustment. Health Care Financ. Rev. 21, 93–118 (2000)PubMedPubMedCentral
13.
go back to reference Van Kleef, R.C., Van Vliet, R.C.J.A., Van Rooijen, E.M.: Diagnoses-based cost groups in the Dutch risk-equalization model: the effects of including outpatient diagnoses. Health Policy 115, 52–59 (2014)CrossRefPubMed Van Kleef, R.C., Van Vliet, R.C.J.A., Van Rooijen, E.M.: Diagnoses-based cost groups in the Dutch risk-equalization model: the effects of including outpatient diagnoses. Health Policy 115, 52–59 (2014)CrossRefPubMed
14.
go back to reference Pope, G.C., Kautter, J., Ellis, R.P., Ash, A.S., Ayanian, J.Z., Lezzoni, L.I., Ingber, M.J., Levy, J.M., Robst, J.: Risk adjustment of medicare capitation payments using the CMS-HCC model. Health Care Financ. Rev. 25, 119–141 (2004)PubMedPubMedCentral Pope, G.C., Kautter, J., Ellis, R.P., Ash, A.S., Ayanian, J.Z., Lezzoni, L.I., Ingber, M.J., Levy, J.M., Robst, J.: Risk adjustment of medicare capitation payments using the CMS-HCC model. Health Care Financ. Rev. 25, 119–141 (2004)PubMedPubMedCentral
15.
go back to reference Hughes, J.S., Averill, R.F., Eisenhandler, J., Goldfield, N.I., Muldoon, J., Neff, J.M., Gay, J.C.: Clinical Risk Groups (CRGs)—a classification system for risk-adjusted capitation-based payment and health care management. Med. Care 42, 81–90 (2004)CrossRefPubMed Hughes, J.S., Averill, R.F., Eisenhandler, J., Goldfield, N.I., Muldoon, J., Neff, J.M., Gay, J.C.: Clinical Risk Groups (CRGs)—a classification system for risk-adjusted capitation-based payment and health care management. Med. Care 42, 81–90 (2004)CrossRefPubMed
16.
go back to reference Kronick, R., Gilmer, T., Dreyfus, T., Lee, L.: Improving health-based payment for medicaid beneficiaries: chronic illness and disability payment system. Health Care Financ. Rev. 21, 29–64 (2000)PubMedPubMedCentral Kronick, R., Gilmer, T., Dreyfus, T., Lee, L.: Improving health-based payment for medicaid beneficiaries: chronic illness and disability payment system. Health Care Financ. Rev. 21, 29–64 (2000)PubMedPubMedCentral
17.
go back to reference Prinsze, F.J., Van Vliet, R.C.J.A.: Health-based risk adjustment: improving the pharmacy-based cost group model by adding diagnostic cost groups. Inquiry 44, 469–480 (2007)PubMed Prinsze, F.J., Van Vliet, R.C.J.A.: Health-based risk adjustment: improving the pharmacy-based cost group model by adding diagnostic cost groups. Inquiry 44, 469–480 (2007)PubMed
18.
go back to reference Zhao, Y., Ellis, R.P., Ash, A.S., Calabrese, D., Ayanian, J.Z., Slaugther, J.P., Weyuker, L., Bowen, B.: Measuring population health risks using inpatient diagnoses and outpatient pharmacy data. Health Serv. Res. 36, 180–193 (2001)PubMedPubMedCentral Zhao, Y., Ellis, R.P., Ash, A.S., Calabrese, D., Ayanian, J.Z., Slaugther, J.P., Weyuker, L., Bowen, B.: Measuring population health risks using inpatient diagnoses and outpatient pharmacy data. Health Serv. Res. 36, 180–193 (2001)PubMedPubMedCentral
19.
go back to reference Lamers, L.M., Van Vliet, R.C.J.A.: The pharmacy-based cost group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation. Health Policy 68, 113–121 (2004)CrossRefPubMed Lamers, L.M., Van Vliet, R.C.J.A.: The pharmacy-based cost group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation. Health Policy 68, 113–121 (2004)CrossRefPubMed
20.
go back to reference Fishman, P.A., Goodman, M.J., Hornbrook, M.C., Meenan, R.T., Bachman, D.J., Rosetti, M.C.K.: Risk adjustment using automated ambulatory pharmacy data. The RxRisk model. Med. Care 41, 84–99 (2003)CrossRefPubMed Fishman, P.A., Goodman, M.J., Hornbrook, M.C., Meenan, R.T., Bachman, D.J., Rosetti, M.C.K.: Risk adjustment using automated ambulatory pharmacy data. The RxRisk model. Med. Care 41, 84–99 (2003)CrossRefPubMed
21.
go back to reference Lamers, L.M., Van Vliet, R.C.J.A.: Health-based risk adjustment: improving the pharmacy-based cost group model to reduce gaming possibilities. Eur. J. Health Econ. 4, 107–114 (2003)CrossRefPubMed Lamers, L.M., Van Vliet, R.C.J.A.: Health-based risk adjustment: improving the pharmacy-based cost group model to reduce gaming possibilities. Eur. J. Health Econ. 4, 107–114 (2003)CrossRefPubMed
22.
go back to reference Van Kleef, R.C., Van Vliet, R.C.J.A.: Prior use of durable medical equipment as a risk adjuster for health-based capitation. Inquiry 47, 343–358 (2010)PubMed Van Kleef, R.C., Van Vliet, R.C.J.A.: Prior use of durable medical equipment as a risk adjuster for health-based capitation. Inquiry 47, 343–358 (2010)PubMed
23.
go back to reference Van Kleef, R.C., Van Vliet, R.C.J.A.: Improving risk equalization using multiple-year high cost as a health indicator. Med. Care 50, 140–144 (2012)CrossRefPubMed Van Kleef, R.C., Van Vliet, R.C.J.A.: Improving risk equalization using multiple-year high cost as a health indicator. Med. Care 50, 140–144 (2012)CrossRefPubMed
24.
go back to reference Ash, A., Porell, F., Gruenberg, L., Sawitz, E., Beiser, A.: Adjusting Medicare capitation payments using prior hospitalization data. Health Care Financ. Rev. 10, 17–29 (1989)PubMedPubMedCentral Ash, A., Porell, F., Gruenberg, L., Sawitz, E., Beiser, A.: Adjusting Medicare capitation payments using prior hospitalization data. Health Care Financ. Rev. 10, 17–29 (1989)PubMedPubMedCentral
25.
go back to reference Ellis, R.P., Ash, A.S.: Refinements to the diagnostic cost group model. Inquiry 32, 1–12 (1995) Ellis, R.P., Ash, A.S.: Refinements to the diagnostic cost group model. Inquiry 32, 1–12 (1995)
26.
go back to reference Ellis, R.P., Pope, G.C., Iezzoni, L.I., Ayanian, J.Z., Bates, D.W., Burstin, H., Ash, A.S.: Diagnosis-based risk adjustment for Medicare capitation payments. Health Care Financ. Rev. 17, 101–128 (1996)PubMedPubMedCentral Ellis, R.P., Pope, G.C., Iezzoni, L.I., Ayanian, J.Z., Bates, D.W., Burstin, H., Ash, A.S.: Diagnosis-based risk adjustment for Medicare capitation payments. Health Care Financ. Rev. 17, 101–128 (1996)PubMedPubMedCentral
27.
go back to reference Lamers, L.M.: Risk-adjusted capitation payments: developing a diagnostic cost groups classification for the Dutch situation. Health Policy 45, 15–32 (1998)CrossRefPubMed Lamers, L.M.: Risk-adjusted capitation payments: developing a diagnostic cost groups classification for the Dutch situation. Health Policy 45, 15–32 (1998)CrossRefPubMed
28.
go back to reference Kronick, R., Dreyfus, T., Lee, L., Zhou, Z.: Diagnostic risk adjustment for Medicaid: the disability payment system. Health Care Financ. Rev. 17, 7–33 (1996)PubMedPubMedCentral Kronick, R., Dreyfus, T., Lee, L., Zhou, Z.: Diagnostic risk adjustment for Medicaid: the disability payment system. Health Care Financ. Rev. 17, 7–33 (1996)PubMedPubMedCentral
29.
go back to reference Clark, D.O., Von Korff, M., Saunders, K., Baluch, W.M., Simon, G.E.: A chronic disease score with empirically derived weights. Med. Care 33, 783–795 (1995)CrossRefPubMed Clark, D.O., Von Korff, M., Saunders, K., Baluch, W.M., Simon, G.E.: A chronic disease score with empirically derived weights. Med. Care 33, 783–795 (1995)CrossRefPubMed
30.
go back to reference Van Kleef R.C., Van Vliet R.C.J.A., Van de Ven W.P.M.M.: Risk equalization 2014: an empirical evaluation. Research report (in Dutch), Erasmus University Rotterdam (2014) Van Kleef R.C., Van Vliet R.C.J.A., Van de Ven W.P.M.M.: Risk equalization 2014: an empirical evaluation. Research report (in Dutch), Erasmus University Rotterdam (2014)
31.
go back to reference Ware, J.E., Kosinski, M., Keller, S.D.: A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med. Care 50, 140–144 (2012)CrossRef Ware, J.E., Kosinski, M., Keller, S.D.: A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med. Care 50, 140–144 (2012)CrossRef
Metadata
Title
Overpaying morbidity adjusters in risk equalization models
Authors
R. C. van Kleef
R. C. J. A. van Vliet
W. P. M. M. van de Ven
Publication date
01-09-2016
Publisher
Springer Berlin Heidelberg
Published in
The European Journal of Health Economics / Issue 7/2016
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-015-0729-2

Other articles of this Issue 7/2016

The European Journal of Health Economics 7/2016 Go to the issue